These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7483399)

  • 1. [The current status of the boron neutron capture therapy of tumors].
    Spryshkova RA; Iagubov AS; Grigor'eva EIu; Koldaeva EIu
    Vopr Onkol; 1995; 41(2):106-7. PubMed ID: 7483399
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation therapy through activation of stable nuclides.
    Carlsson J; Forssell-Aronsson E; Glimelius B;
    Acta Oncol; 2002; 41(7-8):629-34. PubMed ID: 14651206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Boron neutron capture a a new radiotherapy model].
    Hideghéty K; Sauerwwein W; Rassuw J; Sack H
    Orv Hetil; 1998 Mar; 139(12):675-9. PubMed ID: 9555163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
    Deagostino A; Protti N; Alberti D; Boggio P; Bortolussi S; Altieri S; Crich SG
    Future Med Chem; 2016 May; 8(8):899-917. PubMed ID: 27195428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutron capture nuclei-containing carbon nanoparticles for destruction of cancer cells.
    Hwang KC; Lai PD; Chiang CS; Wang PJ; Yuan CJ
    Biomaterials; 2010 Nov; 31(32):8419-25. PubMed ID: 20701966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to magnetic neutron capture therapy.
    Kuznetsov AA; Podoynitsyn SN; Filippov VI; Komissarova LKh; Kuznetsov OA
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):930-3. PubMed ID: 16199321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of radiation effects of gadolinium and boron neutron capture reactions.
    Tokuuye K; Tokita N; Akine Y; Nakayama H; Sakurai Y; Kobayashi T; Kanda K
    Strahlenther Onkol; 2000 Feb; 176(2):81-3. PubMed ID: 10697655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications for clinical treatment from the micrometer site dosimetric calculations in boron neutron capture therapy.
    Nichols TL; Kabalka GW; Miller LF; McCormack MT; Johnson A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S161-3. PubMed ID: 19375932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boronated monoclonal antibody 17-1A for potential neutron capture therapy of colorectal cancer.
    Barth RF; Alam F; Soloway AH; Adams DM; Steplewski Z
    Hybridoma; 1986 Jul; 5 Suppl 1():S43-50. PubMed ID: 3744385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
    Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
    J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of neutrons in cancer therapy: a historical perspective through the modern era.
    Laramore GE
    Semin Oncol; 1997 Dec; 24(6):672-85. PubMed ID: 9422263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [United States and New England medical societies. (7). Boron 10-neutron capture therapy--its history and present status].
    Hatanaka H
    No To Shinkei; 1966 Jul; 18(7):753-5. PubMed ID: 5953683
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurements of low-energy (d,n) reactions for BNCT. Boron Neutron Capture Therapy.
    Colonna N; Beaulieu L; Phair L; Wozniak GJ; Moretto LG; Chu WT; Ludewigt BA
    Med Phys; 1999 May; 26(5):793-8. PubMed ID: 10360544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of neutron capture therapy. Proceedings of a workshop. February 1-2, 1988, Upton, New York.
    Basic Life Sci; 1989; 50():1-370. PubMed ID: 2751599
    [No Abstract]   [Full Text] [Related]  

  • 15. Monte Carlo modelling of the influence of boron microdistribution on BNCT microdosimetry.
    Hugtenburg RP; Baker AE; Green S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S168-70. PubMed ID: 19394241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-Decachloro-o-carborane Derivatives suitable for the preparation of boron-labeled biological macromolecules.
    Gabel D; Walczyna R
    Z Naturforsch C Biosci; 1982 Oct; 37(10):1038-9. PubMed ID: 7180093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of boron compounds in relation to neutron-capture therapy of cancer.
    LOCKSLEY HB; SWEET WH
    Proc Soc Exp Biol Med; 1954 May; 86(1):56-63. PubMed ID: 13177590
    [No Abstract]   [Full Text] [Related]  

  • 18. Toward prompt gamma spectrometry for monitoring boron distributions during extra corporal treatment of liver metastases by boron neutron capture therapy: a Monte Carlo simulation study.
    Khelifi R; Nievaart VA; Bode P; Moss RL; Krijger GC
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S359-61. PubMed ID: 19394243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma.
    Chou FI; Lui WY; Wei YY; Chung RJ; Kai JJ; Chi CW
    Anticancer Res; 1999; 19(3A):1759-64. PubMed ID: 10470112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.